*Mycoplasma genitalium* has recently been cited as a possible cause of pelvic inflammatory disease (PID),[@b1] the inflammation of the female upper genital tract caused by the ascension of organisms from the lower genital tract. As serious sequelae, including tubal factor infertility and chronic pelvic pain frequently follow an episode of PID,[@b2] it is important to identify correlates associated with PID-causing pathogens. As the risk factors associated with *M genitalium* infection among women with PID have not been studied, we sought to describe the demographic, sexual health and behavioural correlates for *M genitalium* in a population of women with clinically suspected PID. We hypothesise that the risk profile of *M genitalium* will be similar to that for *Chlamydia trachomatis* and *Neisseria gonorrhoeae*.

Materials and methods
=====================

Study population
----------------

We analysed baseline data of the PID Evaluation and Clinical Health (PEACH) Study, described in detail elsewhere.[@b3] Women were eligible to participate in the PEACH Study if they had clinically suspected PID, defined by: (1) acute pelvic pain (\<30 days); (2) a clinical finding of pelvic tenderness; and (3) evidence of lower genital tract inflammation. For this ancillary study, stored cervical and endometrial specimens were available from a subset of 586 participants and were tested for *M genitalium*.[@b1] The demographic, behavioural and clinical characteristics of women with available specimens and those without did not differ significantly.

Baseline data collection
------------------------

As part of the parent study, demographic, sexual history and behavioural characteristics were measured by questionnaire, and cervical swabs and endometrial biopsies were analysed for *N gonorrhoeae* by culture and *C trachomatis* by PCR (Roche Diagnostics, Indianapolis, Indiana, USA).[@b3] For this subsequent study, these previously collected cervical and endometrial samples stored at −70°C were tested for *M genitalium* using PCR.[@b1] [@b4]

Statistical methods
-------------------

Associations between *M genitalium* infection and correlates were assessed with univariate and multivariate logistic regression models, the latter which also included variables measuring *C trachomatis* and/or *N gonorrhoeae* infection. As results for lower and upper genital tract *M genitalium* infection were similar, only results for combined cervical and/or endometrial *M genitalium* are presented. The χ^2^ test was used to compare the risk profile of women with *M genitalium* mono-infection with women with *C trachomatis* and/or *N gonorrhoeae*.

Results
=======

Age under 25 years (odds ratio (OR) 2.3, 95% CI 1.3 to 4.1), douching two or more times per month (OR 1.9, 95% CI 1.2 to 3.3) and smoking (OR 1.9, 95% CI 1.2 to 3.1) were significantly associated with *M genitalium* ([table 1](#tbl1){ref-type="table"}).

###### 

Characteristics of study participants and association with *M genitalium* cervical and/or endometrial infection

  Characteristic                                                   *M. genitalium* positive   *M. genitalium* negative   OR (95% CI)        AOR (95% CI)
  ---------------------------------------------------------------- -------------------------- -------------------------- ------------------ ----------------------------------------
  Demographics                                                                                                                              
  Age                                                                                                                                       
   \<25 years                                                      71 (18.2)                  319 (81.8)                 2.3 (1.3 to 4.1)   2.7 (1.5 to 4.7)
   ≥25 years                                                       17 (8.7)                   179 (91.3)                                    
  Race/ethnicity                                                                                                                            
   African-American                                                69 (16.2)                  358 (83.8)                 1.4 (0.8 to 2.4)   --[‡](#table-fn3){ref-type="table-fn"}
   White/Hispanic/other                                            19 (11.9)                  140 (99.1)                                    
  Marital status                                                                                                                            
   Unmarried                                                       71 (14.7)                  411 (85.3)                 1.4 (0.6 to 3.1)   --[‡](#table-fn3){ref-type="table-fn"}
   Married                                                         7 (11.3)                   55 (88.7)                                     
  Education                                                                                                                                 
   \<High school                                                   38 (16.7)                  189 (83.3)                 1.2 (0.8 to 2.0)   --[‡](#table-fn3){ref-type="table-fn"}
   ≥High school                                                    50 (13.9)                  308 (86.0)                                    
  Sexual health                                                                                                                             
  Sexually active                                                                                                                           
   Yes                                                             78 (15.8)                  415 (84.2)                 1.6 (0.8 to 3.1)   --[‡](#table-fn3){ref-type="table-fn"}
   No                                                              10 (10.7)                  83 (89.2)                                     
  Two or more life time sexual partners                                                                                                     
   Yes                                                             10 (17.9)                  46 (82.1)                  1.3 (0.6 to 2.6)   --[‡](#table-fn3){ref-type="table-fn"}
   No                                                              78 (14.7)                  452 (85.3)                                    
  New sexual partner in past month                                                                                                          
   Yes                                                             10 (17.5)                  47 (82.5)                  1.2 (0.6 to 2.5)   --[‡](#table-fn3){ref-type="table-fn"}
   No                                                              78 (14.7)                  451 (85.3)                                    
  History of STI[§](#table-fn4){ref-type="table-fn"}                                                                                        
   Yes                                                             52 (15.0)                  295 (85.0)                 1.0 (0.6 to 1.6)   --[‡](#table-fn3){ref-type="table-fn"}
   No                                                              35 (15.0)                  198 (85.0)                                    
  History of bacterial vaginosis                                                                                                            
   Yes                                                             13 (10.0)                  117 (90.0)                 0.6 (0.3 to 1.0)   --[‡](#table-fn3){ref-type="table-fn"}
   No                                                              73 (16.7)                  365 (83.3)                                    
  History of PID                                                                                                                            
   Yes                                                             23 (12.9)                  155 (87.1)                 0.8 (0.5 to 1.3)   --[‡](#table-fn3){ref-type="table-fn"}
   No                                                              64 (15.9)                  338 (84.1)                                    
  Hormonal contraception use                                                                                                                
   Yes                                                             17 (15.6)                  92 (84.4)                  0.9 (0.5 to 1.8)   --[‡](#table-fn3){ref-type="table-fn"}
   No                                                              61 (15.9)                  323 (84.1)                                    
  Rare/occasional condom use[¶](#table-fn5){ref-type="table-fn"}                                                                            
   Yes                                                             60 (17.2)                  289 (82.8)                 1.4 (0.8 to 2.6)   --[‡](#table-fn3){ref-type="table-fn"}
   No                                                              18 (12.5)                  126 (87.5)                                    
  Consistent condom use[\*\*](#table-fn6){ref-type="table-fn"}                                                                              
   Yes                                                             7 (10.9)                   57 (89.1)                  1.2 (0.5 to 2.7)   --[‡](#table-fn3){ref-type="table-fn"}
   No                                                              71 (16.5)                  358 (83.5)                                    
  Oral sex                                                                                                                                  
   Yes                                                             23 (17.6)                  108 (82.4)                 1.2 (0.7 to 2.0)   --[‡](#table-fn3){ref-type="table-fn"}
   No                                                              63 (15.0)                  356 (85.0)                                    
  Anal sex                                                                                                                                  
   Yes                                                             4 (21.1)                   15 (78.9)                  1.5 (0.5 to 4.7)   --[‡](#table-fn3){ref-type="table-fn"}
   No                                                              84 (14.8)                  483 (85.2)                                    
  Age at sexual debut                                                                                                                       
   ≤15 years                                                       48 (15.8)                  255 (84.2)                 1.1 (0.7 to 1.8)   --[‡](#table-fn3){ref-type="table-fn"}
   \>15 years                                                      40 (14.1)                  243 (85.9)                                    
  Behavioural                                                                                                                               
  Vaginal douche two or more times in past month                                                                                            
   Yes                                                             26 (22.8)                  88 (77.8)                  1.9 (1.2 to 3.3)   2.0 (1.2 to 3.4)
   No                                                              62 (13.1)                  410 (86.9)                                    
  Illicit drug use                                                                                                                          
   Yes                                                             32 (20.4)                  125 (79.6)                 1.7 (1.0 to 2.7)   --[‡](#table-fn3){ref-type="table-fn"}
   No                                                              56 (13.1)                  370 (86.9)                                    
  Current smoker                                                                                                                            
   Yes                                                             49 (20.2)                  194 (79.8)                 1.9 (1.2 to 3.1)   2.0 (1.3 to 3.3)
   No                                                              39 (11.5)                  301 (88.5)                                    
  Alcohol use                                                                                                                               
   Yes                                                             48 (14.8)                  277 (85.2)                 0.9 (0.6 to 1.5)   --[‡](#table-fn3){ref-type="table-fn"}
   No                                                              40 (15.5)                  218 (84.5)                                    
  Alcohol drinks per week                                                                                                                   
   \>7 drinks                                                      13 (19.1)                  55 (80.9)                  1.4 (0.7 to 2.7)   --[‡](#table-fn3){ref-type="table-fn"}
   ≤7 drinks                                                       75 (14.6)                  440 (85.4)                                    

Missing observations: marital status, n = 42; education, n = 1; history of sexually transmitted infection (STI), n = 6; history of bacterial vaginosis, n = 18; history of pelvic inflammatory disease (PID), n = 6; hormonal contraception use, n = 93; condom use, n = 93; oral sex, n = 36; drug use, n = 3; smoking, n = 3, alcohol use, n = 3.

Percentage of total study population with characteristic that tested positive for *M genitalium.*

Percentage of total study population with characteristic that tested negative for *M genitalium.*

Variables with a p value greater than 0.10 were not included in the multivariate analysis.

History of *N gonorrhoeae*, *C trachomatis*, or *Trichonomas vaginalis.*

Condoms used 0 to 5 out of 10 sexual encounters.

Condoms used 10 out of 10 sexual encounters. AOR, adjusted odds ratio; OR, odds ratio.

In a multivariate model adjusting for the above variables, age less than 25 years (adjusted odds ratio (AOR) 2.7, 95% CI 1.5 to 4.7), douching (AOR 2.0, 95% CI 1.2 to 3.4) and smoking (AOR 2.0, 95% CI 1.3 to 3.3) were independently associated with *M genitalium*. After further adjusting for *C trachomatis* and/or *N gonorrhoeae* infection, age (AOR 3.0, 95% CI 1.4 to 6.2) and smoking (AOR 1.9, 95% CI 1.1 to 3.3) remained significantly associated with *M genitalium*.

Women with *M genitalium* mono-infection (n = 22) were generally similar to women with *C trachomatis* and/or *N gonorrhoeae* (n = 172) (results not shown). The only characteristic that differed between these two groups was race. Women with *M genitalium* mono-infection were significantly less likely to be African-American (59.1% vs 86.0%, p = 0.001) than women with *C trachomatis* and/or *N gonorrhoeae*.

Discussion
==========

Among women with clinically suspected PID, compared with women who tested negative, women positive for *M genitalium* in the cervix and/or endometrium were more likely to have some characteristics and behaviours that are commonly associated with other sexually transmitted infections (STI) and PID, including young age, smoking and douching. Furthermore, the characteristics of *M genitalium* were similar to those of *N gonorrhoeae* and *C trachomatis*. However, *M genitalium* infection was not associated with all traditional markers of STI, including sexual activity, number of sexual partners, new sexual partner, history of STI or PID, condom use, oral and anal sex and age at sexual debut. Our findings are not consistent with other studies that have examined the risk factors for *M genitalium* lower genital tract infection.[@b5; @b6; @b7] However, all women enrolled in our study had clinically suspected PID. Therefore, they may have had a homogeneity of sexual risk behaviours, which probably biased these variables towards the null.

As patients infected with *M genitalium* may have mild symptoms,[@b5] [@b7] [@b8] an understanding of risk factors may aid efforts to reduce the acquisition, spread and complications of infection. As clinicians may use certain risk factors to decide who to screen for STI, including *N gonorrhoeae* and *C trachomatis*, and the risk factors for these pathogens and *M genitalium* are largely the same, these same women should also be screened for *M genitalium*. Such screening efforts could help detect and treat uncomplicated lower genital tract *M genitalium* infections, which could ultimately prevent some PID cases.
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